{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T08:01:50Z","timestamp":1788854510964,"version":"build-2803163510"},"reference-count":280,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is currently among the most common liver diseases. Unfavorable data on the epidemiology of metabolic syndrome and obesity have increased the attention of clinicians and researchers to the problem of NAFLD. The research results allow us to emphasize the systemicity and multifactoriality of the pathogenesis of liver parenchyma lesion. At the same time, many aspects of its classification, etiology, and pathogenesis remain controversial. Local and systemic metabolic disorders are also a part of the pathogenesis of chronic obstructive pulmonary disease and can influence its course. The present article analyzes the metabolic pathways mediating the links of impaired lipid metabolism in NAFLD and chronic obstructive pulmonary disease (COPD). Free fatty acids, cholesterol, and ceramides are involved in key metabolic and inflammatory pathways underlying the pathogenesis of both diseases. Moreover, inflammation and lipid metabolism demonstrate close links in the comorbid course of NAFLD and COPD.<\/jats:p>","DOI":"10.3390\/cells10112978","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T22:21:08Z","timestamp":1635805268000},"page":"2978","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7083-2692","authenticated-orcid":false,"given":"Stanislav","family":"Kotlyarov","sequence":"first","affiliation":[{"name":"Department of Nursing, Ryazan State Medical University, 390026 Ryazan, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksei","family":"Bulgakov","sequence":"additional","affiliation":[{"name":"Department of Nursing, Ryazan State Medical University, 390026 Ryazan, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","article-title":"The Global Epidemic of the Metabolic Syndrome","volume":"20","author":"Saklayen","year":"2018","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/13814788.2020.1851676","article-title":"Burden of metabolic syndrome among primary care patients in Crete, Greece: A descriptive study","volume":"26","author":"Anastasaki","year":"2020","journal-title":"Eur. J. Gen. Pract."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"14995","DOI":"10.1038\/s41598-018-33177-5","article-title":"Prevalence of the Metabolic Syndrome and its determinants among Nepalese adults: Findings from a nationally representative cross-sectional study","volume":"8","author":"Mehata","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.21037\/tgh.2019.09.08","article-title":"Epidemiology of non-alcoholic and alcoholic fatty liver diseases","volume":"5","author":"Mitra","year":"2020","journal-title":"Transl. Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Ge, X., Zheng, L., Wang, M., Du, Y., and Jiang, J. (2020). Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990-2017: A population-based observational study. BMJ Open, 10.","DOI":"10.1136\/bmjopen-2019-036663"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.dld.2015.08.004","article-title":"Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups","volume":"47","author":"Lonardo","year":"2015","journal-title":"Dig. Liver Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1053\/j.gastro.2017.01.003","article-title":"Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease among Patients with Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation","volume":"152","author":"Goldberg","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/hep.23594","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection","volume":"51","author":"Starley","year":"2010","journal-title":"Hepatology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MD.0b013e3182779d49","article-title":"Nonalcoholic fatty liver disease in lean individuals in the United States","volume":"91","author":"Younossi","year":"2012","journal-title":"Medicine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.22429","article-title":"Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes","volume":"48","author":"Fracanzani","year":"2008","journal-title":"Hepatology"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"The Italian Association for the Study of the Liver (AISF) (2017). AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions. Dig. Liver Dis., 49, 471\u2013483.","DOI":"10.1016\/j.dld.2017.01.147"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jhep.2010.04.008","article-title":"A position statement on NAFLD\/NASH based on the EASL 2009 special conference","volume":"53","author":"Ratziu","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.7326\/0003-4819-132-2-200001180-00004","article-title":"Prevalence of and risk factors for hepatic steatosis in Northern Italy","volume":"132","author":"Bellentani","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1586\/17474124.2015.965143","article-title":"Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease","volume":"9","author":"Lonardo","year":"2015","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1601923","DOI":"10.1183\/13993003.01923-2016","article-title":"Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease","volume":"49","author":"Viglino","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"16559","DOI":"10.1038\/s41598-018-34988-2","article-title":"Impact of Non-alcoholic Fatty Liver Disease on long-term cardiovascular events and death in Chronic Obstructive Pulmonary Disease","volume":"8","author":"Viglino","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Song, J.U., Jang, Y., Lim, S.Y., Ryu, S., Song, W.J., Byrne, C.D., and Sung, K.C. (2019). Decreased lung function is associated with risk of developing non-alcoholic fatty liver disease: A longitudinal cohort study. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0208736"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1445-5994.2011.02644.x","article-title":"Relationship between non-alcoholic fatty liver disease and pulmonary function","volume":"42","author":"Jung","year":"2012","journal-title":"Intern. Med. J."},{"key":"ref_22","first-page":"64","article-title":"Comorbidities and Nonalcoholic Fatty Liver Disease: The Chicken, the Egg, or Both?","volume":"36","author":"Glass","year":"2019","journal-title":"Fed. Pract."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/hepr.12656","article-title":"The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment","volume":"46","author":"Ballestri","year":"2016","journal-title":"Hepatol. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/jgh.13264","article-title":"Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis","volume":"31","author":"Ballestri","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Tana, C., Ballestri, S., Ricci, F., Di Vincenzo, A., Ticinesi, A., Gallina, S., Giamberardino, M.A., Cipollone, F., Sutton, R., and Vettor, R. (2019). Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications. Int. J. Environ. Res. Public Health, 16.","DOI":"10.3390\/ijerph16173104"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11894-009-0008-4","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk","volume":"11","author":"Misra","year":"2009","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","article-title":"NAFLD and cardiovascular diseases: A clinical review","volume":"110","author":"Kasper","year":"2021","journal-title":"Clin. Res. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15280\/jlm.2015.5.1.7","article-title":"Comorbidities and Metabolic Derangement of NAFLD","volume":"5","author":"Bang","year":"2015","journal-title":"J. Lifestyle Med."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Rosato, V., Masarone, M., Dallio, M., Federico, A., Aglitti, A., and Persico, M. (2019). NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome. Int. J. Environ. Res. Public Health, 16.","DOI":"10.3390\/ijerph16183415"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2119\/2007-00119.Tilg","article-title":"Inflammatory mechanisms in the regulation of insulin resistance","volume":"14","author":"Tilg","year":"2008","journal-title":"Mol. Med."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Kitade, H., Chen, G., Ni, Y., and Ota, T. (2017). Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments. Nutrients, 9.","DOI":"10.3390\/nu9040387"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-pathol-121808-102132","article-title":"Nonalcoholic fatty liver disease: Pathology and pathogenesis","volume":"5","author":"Tiniakos","year":"2010","journal-title":"Annu. Rev. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.clinre.2019.04.005","article-title":"Non-Alcoholic Fatty Liver Disease in Non-Obese Individuals: Prevalence, Pathogenesis and Treatment","volume":"43","author":"Krawczyk","year":"2019","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1111\/jgh.14585","article-title":"Characteristics of non-alcoholic steatohepatitis among lean patients in Japan: Not uncommon and not always benign","volume":"34","author":"Tobari","year":"2019","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Adams, L.C., L\u00fcbbe, F., Bressem, K., Wagner, M., Hamm, B., and Makowski, M.R. (2018). Non-alcoholic fatty liver disease in underweight patients with inflammatory bowel disease: A case-control study. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0206450"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.gtc.2019.09.003","article-title":"Nutrition and Nonalcoholic Fatty Liver Disease: Current Perspectives","volume":"49","author":"Chakravarthy","year":"2020","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3748\/wjg.v18.i8.727","article-title":"Role of cytokines and chemokines in non-alcoholic fatty liver disease","volume":"18","author":"Braunersreuther","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/jgh3.12114","article-title":"Association between non-alcoholic fatty liver disease evaluated by transient elastography with extracranial carotid atherosclerosis in a multiethnic Asian community","volume":"3","author":"Tan","year":"2019","journal-title":"JGH Open"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/hep.23567","article-title":"Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease","volume":"51","author":"Das","year":"2010","journal-title":"Hepatology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep.30908","article-title":"Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation","volume":"71","author":"Chen","year":"2020","journal-title":"Hepatology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/hep4.1519","article-title":"Prevalence and Profile of Nonalcoholic Fatty Liver Disease in Lean Adults: Systematic Review and Meta-Analysis","volume":"4","author":"Young","year":"2020","journal-title":"Hepatol. Commun."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.15403\/jgld.2014.1121.271.kby","article-title":"A Multi-strain Probiotic Reduces the Fatty Liver Index, Cytokines and Aminotransferase levels in NAFLD Patients: Evidence from a Randomized Clinical Trial","volume":"27","author":"Kobyliak","year":"2018","journal-title":"J. Gastrointestin. Liver Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia","volume":"67","author":"Fan","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1001\/jama.2009.726","article-title":"Diabetes in Asia: Epidemiology, risk factors, and pathophysiology","volume":"301","author":"Chan","year":"2009","journal-title":"JAMA"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Uz-Zaman, M.H., Rahman, A., and Yasmin, M. (2018). Epidemiology of Hepatitis B Virus Infection in Bangladesh: Prevalence among General Population, Risk Groups and Genotype Distribution. Genes, 9.","DOI":"10.20944\/preprints201809.0092.v1"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Rahman, M.M., Kibria, M.G., Begum, H., Haque, M., Sultana, N., Akhter, M., Rowshon, A.H.M., Ahmed, F., and Hasan, M. (2020). Prevalence, risk factors and metabolic profile of the non-obese and obese non-alcoholic fatty liver disease in a rural community of South Asia. BMJ Open Gastroenterol., 7.","DOI":"10.1136\/bmjgast-2020-000535"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/liv.13983","article-title":"Predictors of nonalcoholic steatohepatitis and significant fibrosis in non-obese nonalcoholic fatty liver disease","volume":"39","author":"Kim","year":"2019","journal-title":"Liver Int."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/gutjnl-2018-317666","article-title":"Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: Evidence from the Kangbuk Samsung Health Study","volume":"68","author":"Chang","year":"2019","journal-title":"Gut"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e6712","DOI":"10.1097\/MD.0000000000006712","article-title":"Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: A post hoc analysis of a cohort study","volume":"96","author":"Yoshitaka","year":"2017","journal-title":"Medicine"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.3748\/wjg.v13.i26.3540","article-title":"Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease","volume":"13","author":"Qureshi","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: Disentangling microbial signatures from metabolic disorders","volume":"17","author":"Vigliotti","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_53","first-page":"334","article-title":"Non-alcoholic fatty liver disease: The problems we are facing","volume":"2","author":"Wang","year":"2003","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.plipres.2012.11.002","article-title":"Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis","volume":"52","author":"Musso","year":"2013","journal-title":"Prog. Lipid Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"ref_57","first-page":"11","article-title":"Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease","volume":"7","author":"Zhou","year":"2021","journal-title":"Hepatoma Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3389\/fendo.2020.00505","article-title":"Too Much of a Good Thing? An Evolutionary Theory to Explain the Role of Ceramides in NAFLD","volume":"11","author":"Poss","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1172\/JCI24930","article-title":"Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease","volume":"115","author":"Tamura","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.plipres.2014.02.002","article-title":"Recent insights into the molecular pathophysiology of lipid droplet formation in hepatocytes","volume":"54","author":"Sahini","year":"2014","journal-title":"Prog. Lipid Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"44507","DOI":"10.1074\/jbc.M207712200","article-title":"The surface of lipid droplets is a phospholipid monolayer with a unique Fatty Acid composition","volume":"277","author":"Ozeki","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrgastro.2017.32","article-title":"Lipid droplets and liver disease: From basic biology to clinical implications","volume":"14","author":"Gluchowski","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/B978-0-12-408051-5.00007-3","article-title":"Analysis of lipid droplets in hepatocytes","volume":"116","author":"Wang","year":"2013","journal-title":"Methods Cell Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12944-017-0521-7","article-title":"Lipid Droplets in Health and Disease","volume":"16","author":"Onal","year":"2017","journal-title":"Lipids Health Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.cell.2009.11.005","article-title":"Lipid droplets finally get a little R-E-S-P-E-C-T","volume":"139","author":"Farese","year":"2009","journal-title":"Cell"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jgg.2014.03.003","article-title":"Recent advances in understanding proteins involved in lipid droplet formation, growth and fusion","volume":"41","author":"Tan","year":"2014","journal-title":"J. Genet. Genom."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"101115","DOI":"10.1016\/j.molmet.2020.101115","article-title":"Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD","volume":"50","author":"Mashek","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1083\/jcb.201803153","article-title":"Lipid droplet size directs lipolysis and lipophagy catabolism in hepatocytes","volume":"218","author":"Schott","year":"2019","journal-title":"J. Cell Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cmet.2007.05.005","article-title":"Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver","volume":"6","author":"Monetti","year":"2007","journal-title":"Cell Metab."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/hep.21788","article-title":"Good fat\/bad fat","volume":"45","author":"McClain","year":"2007","journal-title":"Hepatology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1073\/pnas.0630588100","article-title":"Triglyceride accumulation protects against fatty acid-induced lipotoxicity","volume":"100","author":"Listenberger","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/hep.21655","article-title":"Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis","volume":"45","author":"Yamaguchi","year":"2007","journal-title":"Hepatology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1586\/egh.09.32","article-title":"Lipotoxicity in nonalcoholic fatty liver disease: Not all lipids are created equal","volume":"3","author":"Alkhouri","year":"2009","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41419-020-03003-w","article-title":"Understanding lipotoxicity in NAFLD pathogenesis: Is CD36 a key driver?","volume":"11","author":"Rada","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1038\/srep05832","article-title":"Association between serum free fatty acid levels and nonalcoholic fatty liver disease: A cross-sectional study","volume":"4","author":"Zhang","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Gambino, R., Bugianesi, E., Rosso, C., Mezzabotta, L., Pinach, S., Alemanno, N., Saba, F., and Cassader, M. (2016). Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17040479"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1074\/jbc.M807616200","article-title":"Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: Role of stearoyl-CoA desaturase","volume":"284","author":"Li","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez Gianotti, T., Burgue\u00f1o, A., Gonzales Mansilla, N., Pirola, C.J., and Sookoian, S. (2013). Fatty liver is associated with transcriptional downregulation of stearoyl-CoA desaturase and impaired protein dimerization. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076912"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"E2288","DOI":"10.1210\/jc.2012-2152","article-title":"High hepatic SCD1 activity is associated with low liver fat content in healthy subjects under a lipogenic diet","volume":"97","author":"Silbernagel","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.cmet.2018.03.014","article-title":"Evidence that TLR4 Is Not a Receptor for Saturated Fatty Acids but Mediates Lipid-Induced Inflammation by Reprogramming Macrophage Metabolism","volume":"27","author":"Lancaster","year":"2018","journal-title":"Cell Metab."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Rogero, M.M., and Calder, P.C. (2018). Obesity, Inflammation, Toll-Like Receptor 4 and Fatty Acids. Nutrients, 10.","DOI":"10.3390\/nu10040432"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ecl.2008.06.007","article-title":"Obesity and free fatty acids","volume":"37","author":"Boden","year":"2008","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1172\/JCI28898","article-title":"TLR4 links innate immunity and fatty acid-induced insulin resistance","volume":"116","author":"Shi","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejphar.2016.04.024","article-title":"Mechanisms for the activation of Toll-like receptor 2\/4 by saturated fatty acids and inhibition by docosahexaenoic acid","volume":"785","author":"Hwang","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00011-019-01273-5","article-title":"The effect of palmitic acid on inflammatory response in macrophages: An overview of molecular mechanisms","volume":"68","author":"Korbecki","year":"2019","journal-title":"Inflamm. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.bbrc.2017.06.047","article-title":"Chronic intermittent hypoxia induces liver fibrosis in mice with diet-induced obesity via TLR4\/MyD88\/MAPK\/NF-kB signaling pathways","volume":"490","author":"Kang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"615978","DOI":"10.3389\/fmed.2021.615978","article-title":"Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment","volume":"8","author":"Heyens","year":"2021","journal-title":"Front. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2147\/COPD.S242863","article-title":"Hepatic Fibrosis Assessed Using Fibrosis-4 Index Is Predictive of All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease","volume":"15","author":"Yong","year":"2020","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Boeckmans, J., Natale, A., Rombaut, M., Buyl, K., Rogiers, V., De Kock, J., Vanhaecke, T., and Rodrigues, R.M. (2019). Anti-NASH Drug Development Hitches a Lift on PPAR Agonism. Cells, 9.","DOI":"10.3390\/cells9010037"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pharmthera.2017.05.011","article-title":"Targeting nuclear receptors for the treatment of fatty liver disease","volume":"179","author":"Tanaka","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.bbalip.2007.04.018","article-title":"Modulation of PPAR activity via phosphorylation","volume":"1771","author":"Burns","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.semcdb.2012.01.003","article-title":"PPARs: Fatty acid sensors controlling metabolism","volume":"23","author":"Poulsen","year":"2012","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.redox.2017.02.025","article-title":"Impact of high cholesterol and endoplasmic reticulum stress on metabolic diseases: An updated mini-review","volume":"12","author":"Sozen","year":"2017","journal-title":"Redox Biol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatology"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/hep.23229","article-title":"The plasma lipidomic signature of nonalcoholic steatohepatitis","volume":"50","author":"Puri","year":"2009","journal-title":"Hepatology"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tem.2015.11.008","article-title":"The Role of Cholesterol in the Pathogenesis of NASH","volume":"27","author":"Ioannou","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jhep.2008.12.016","article-title":"Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH","volume":"50","author":"Caballero","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jhep.2014.07.024","article-title":"Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent","volume":"61","author":"Gan","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1194\/jlr.M034876","article-title":"Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis","volume":"54","author":"Ioannou","year":"2013","journal-title":"J. Lipid Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1053\/j.gastro.2011.09.049","article-title":"A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells","volume":"142","author":"Teratani","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/hep.26604","article-title":"Free cholesterol accumulation in hepatic stellate cells: Mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice","volume":"59","author":"Tomita","year":"2014","journal-title":"Hepatology"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Roehlen, N., Crouchet, E., and Baumert, T.F. (2020). Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells, 9.","DOI":"10.3390\/cells9040875"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","article-title":"Mechanisms and regulation of cholesterol homeostasis","volume":"21","author":"Luo","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3389\/fmed.2020.00467","article-title":"Disturbances in Cholesterol Homeostasis and Non-alcoholic Fatty Liver Diseases","volume":"7","author":"Malhotra","year":"2020","journal-title":"Front. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1194\/jlr.M069807","article-title":"Cholesterol 7\u03b1-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis","volume":"57","author":"Liu","year":"2016","journal-title":"J. Lipid Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cmet.2012.04.004","article-title":"Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease","volume":"15","author":"Min","year":"2012","journal-title":"Cell Metab."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/liv.13109","article-title":"Hepatic miR-33a\/miR-144 and their target gene ABCA1 are associated with steatohepatitis in morbidly obese subjects","volume":"36","year":"2016","journal-title":"Liver Int."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Hussein, M.A., Shrestha, E., Ouimet, M., Barrett, T.J., Leone, S., Moore, K.J., H\u00e9rault, Y., Fisher, E.A., and Garabedian, M.J. (2015). LXR-Mediated ABCA1 Expression and Function Are Modulated by High Glucose and PRMT2. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0135218"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1097-2765(01)00164-2","article-title":"A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis","volume":"7","author":"Chawla","year":"2001","journal-title":"Mol. Cell"},{"key":"ref_110","first-page":"1869","article-title":"Expression of LXR-\u03b2, ABCA1 and ABCG1 in human triple-negative breast cancer tissues","volume":"42","author":"Pan","year":"2019","journal-title":"Oncol Rep."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Kotlyarov, S. (2021). Participation of ABCA1 Transporter in Pathogenesis of Chronic Obstructive Pulmonary Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073334"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1191\/1358863x05vm593ra","article-title":"ABCA1 and atherosclerosis","volume":"10","author":"Soumian","year":"2005","journal-title":"Vasc. Med."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5551\/jat.13.1","article-title":"ABCA1 and biogenesis of HDL","volume":"13","author":"Yokoyama","year":"2006","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12931-017-0526-9","article-title":"Examining the role of ABC lipid transporters in pulmonary lipid homeostasis and inflammation","volume":"18","author":"Chai","year":"2017","journal-title":"Respir. Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"25448","DOI":"10.1074\/jbc.M301189200","article-title":"Specific gene expression of ATP-binding cassette transporters and nuclear hormone receptors in rat liver parenchymal, endothelial, and Kupffer cells","volume":"278","author":"Hoekstra","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"108778","DOI":"10.1016\/j.biopha.2019.108778","article-title":"Biological mechanisms and related natural modulators of liver X receptor in nonalcoholic fatty liver disease","volume":"113","author":"Ni","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41574-018-0037-x","article-title":"Liver X receptors in lipid signalling and membrane homeostasis","volume":"14","author":"Wang","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1755-5922.2008.00062.x","article-title":"Liver X receptors (LXR) as therapeutic targets in dyslipidemia","volume":"26","year":"2008","journal-title":"Cardiovasc. Ther."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.bbrc.2005.12.137","article-title":"Niemann-Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine","volume":"340","author":"Duval","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.tem.2012.10.004","article-title":"Atherosclerosis: Lessons from LXR and the intestine","volume":"24","author":"Bonamassa","year":"2013","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00395-015-0520-7","article-title":"Emerging role of liver X receptors in cardiac pathophysiology and heart failure","volume":"111","author":"Cannon","year":"2016","journal-title":"Basic Res. Cardiol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/bph.14156","article-title":"Functional interplay between liver X receptor and AMP-activated protein kinase \u03b1 inhibits atherosclerosis in apolipoprotein E-deficient mice\u2014A new anti-atherogenic strategy","volume":"175","author":"Ma","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"E6556","DOI":"10.1073\/pnas.1721245115","article-title":"Disrupting LXR\u03b1 phosphorylation promotes FoxM1 expression and modulates atherosclerosis by inducing macrophage proliferation","volume":"115","author":"Gage","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.imbio.2005.05.007","article-title":"The innate immune response under the control of the LXR pathway","volume":"210","author":"Valledor","year":"2005","journal-title":"Immunobiology"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.cell.2017.12.026","article-title":"LXR\/ApoE Activation Restricts Innate Immune Suppression in Cancer","volume":"172","author":"Tavazoie","year":"2018","journal-title":"Cell"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1523-1747.2003.12033.x","article-title":"Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: Liver-X-receptor-specific inhibition of inflammation and primary cytokine production","volume":"120","author":"Fowler","year":"2003","journal-title":"J. Investig. Dermatol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1101\/gad.844900","article-title":"Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta","volume":"14","author":"Repa","year":"2000","journal-title":"Genes Dev."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1073\/pnas.1805128115","article-title":"Rational application of macrophage-specific LXR agonists avoids the pitfalls of SREBP-induced lipogenesis","volume":"115","author":"Magida","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1194\/jlr.M300473-JLR200","article-title":"LXR\/RXR ligand activation enhances basolateral efflux of beta-sitosterol in CaCo-2 cells","volume":"45","author":"Field","year":"2004","journal-title":"J. Lipid Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jsbmb.2011.10.006","article-title":"The liver X receptor modulator 22(S)-hydroxycholesterol exerts cell-type specific effects on lipid and glucose metabolism","volume":"128","author":"Hessvik","year":"2012","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1017\/S0007114511006854","article-title":"Regulation of the expression of key genes involved in HDL metabolism by unsaturated fatty acids","volume":"108","author":"Kuang","year":"2012","journal-title":"Br. J. Nutr."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nrd4280","article-title":"Liver X receptors in lipid metabolism: Opportunities for drug discovery","volume":"13","author":"Hong","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"E210","DOI":"10.1152\/ajpendo.00541.2010","article-title":"Liver X receptors regulate de novo lipogenesis in a tissue-specific manner in C57BL\/6 female mice","volume":"301","author":"Archer","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Dixon, E.D., Nardo, A.D., Claudel, T., and Trauner, M. (2021). The Role of Lipid Sensing Nuclear Receptors (PPARs and LXR) and Metabolic Lipases in Obesity, Diabetes and NAFLD. Genes, 12.","DOI":"10.3390\/genes12050645"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1101\/gad.850400","article-title":"Role of LXRs in control of lipogenesis","volume":"14","author":"Schultz","year":"2000","journal-title":"Genes Dev."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1872-034X.2008.00382.x","article-title":"Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease","volume":"38","author":"Higuchi","year":"2008","journal-title":"Hepatol. Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1074\/jbc.M605023200","article-title":"The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR","volume":"282","author":"Cha","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_138","first-page":"127","article-title":"The significance and effects of liver X receptor alpha in nonalcoholic fatty liver disease in rats","volume":"15","author":"Ai","year":"2007","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Ito, A., Hong, C., Rong, X., Zhu, X., Tarling, E.J., Hedde, P.N., Gratton, E., Parks, J., and Tontonoz, P. (2015). LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling. eLife, 4.","DOI":"10.7554\/eLife.08009"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s10620-011-1902-9","article-title":"Activation of liver X receptors attenuates endotoxin-induced liver injury in mice with nonalcoholic fatty liver disease","volume":"57","author":"Liu","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: Lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1529\/biophysj.104.057851","article-title":"Different effects of long- and short-chain ceramides on the gel-fluid and lamellar-hexagonal transitions of phospholipids: A calorimetric, NMR, and x-ray diffraction study","volume":"88","author":"Sot","year":"2005","journal-title":"Biophys. J."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bbamem.2005.02.014","article-title":"Molecular associations and surface-active properties of short- and long-N-acyl chain ceramides","volume":"1711","author":"Sot","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bpc.2017.03.004","article-title":"Permeability and microstructure of model stratum corneum lipid membranes containing ceramides with long (C16) and very long (C24) acyl chains","volume":"224","author":"Maixner","year":"2017","journal-title":"Biophys. Chem."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1042\/bss0720177","article-title":"Biophysics (and sociology) of ceramides","volume":"72","author":"Contreras","year":"2005","journal-title":"Biochem. Soc. Symp."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bbamem.2008.07.030","article-title":"Ceramide-enriched membrane domains--structure and function","volume":"1788","author":"Zhang","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"9997","DOI":"10.1074\/jbc.M309992200","article-title":"Ceramide selectively displaces cholesterol from ordered lipid domains (rafts): Implications for lipid raft structure and function","volume":"279","author":"Megha","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.febslet.2010.02.026","article-title":"Ceramide-rich platforms in transmembrane signaling","volume":"584","author":"Stancevic","year":"2010","journal-title":"FEBS Lett."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10863-005-6567-7","article-title":"Mitochondrial ceramide and the induction of apoptosis","volume":"37","author":"Siskind","year":"2005","journal-title":"J. Bioenerg. Biomembr."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/ATVBAHA.118.311199","article-title":"Plasma Ceramides","volume":"38","author":"Meeusen","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1194\/jlr.C088377","article-title":"The ceramide ratio: A predictor of cardiometabolic risk","volume":"59","author":"Tippetts","year":"2018","journal-title":"J. Lipid Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/eurheartj\/ehz387","article-title":"Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients","volume":"41","author":"Hilvo","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/j.celrep.2017.02.019","article-title":"Plasma Dihydroceramides Are Diabetes Susceptibility Biomarker Candidates in Mice and Humans","volume":"18","author":"Wigger","year":"2017","journal-title":"Cell Rep."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.cmet.2014.08.002","article-title":"Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance","volume":"20","author":"Turpin","year":"2014","journal-title":"Cell Metab."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/ijo.2012.191","article-title":"Plasma sphingolipids are biomarkers of metabolic syndrome in non-human primates maintained on a Western-style diet","volume":"37","author":"Brozinick","year":"2013","journal-title":"Int. J. Obes."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/oby.21448","article-title":"Skeletal muscle and plasma lipidomic signatures of insulin resistance and overweight\/obesity in humans","volume":"24","author":"Tonks","year":"2016","journal-title":"Obesity"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"684448","DOI":"10.3389\/fendo.2021.684448","article-title":"Circulating Ceramides- Are Origins Important for Sphingolipid Biomarkers and Treatments?","volume":"12","author":"Mah","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cmet.2015.06.007","article-title":"Targeted Induction of Ceramide Degradation Leads to Improved Systemic Metabolism and Reduced Hepatic Steatosis","volume":"22","author":"Xia","year":"2015","journal-title":"Cell Metab."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"13834","DOI":"10.1074\/jbc.270.23.13834","article-title":"Sphingolipid biosynthesis de novo by rat hepatocytes in culture. Ceramide and sphingomyelin are associated with, but not required for, very low density lipoprotein secretion","volume":"270","author":"Merrill","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"100154","DOI":"10.1016\/j.xcrm.2020.100154","article-title":"Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes","volume":"1","author":"Carlier","year":"2020","journal-title":"Cell Rep. Med."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2012.04.005","article-title":"Role of ceramides in nonalcoholic fatty liver disease","volume":"23","author":"Pagadala","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/s42255-019-0134-8","article-title":"Metabolic Messengers: Ceramides","volume":"1","author":"Summers","year":"2019","journal-title":"Nat. Metab."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.aav3722","article-title":"Targeting a ceramide double bond improves insulin resistance and hepatic steatosis","volume":"365","author":"Chaurasia","year":"2019","journal-title":"Science"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1172\/JCI43378","article-title":"Lipid-induced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice","volume":"121","author":"Holland","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"7254","DOI":"10.1021\/bi400914c","article-title":"CD36 enhances fatty acid uptake by increasing the rate of intracellular esterification but not transport across the plasma membrane","volume":"52","author":"Xu","year":"2013","journal-title":"Biochemistry"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.plefa.2016.05.005","article-title":"The enigmatic membrane fatty acid transporter CD36: New insights into fatty acid binding and their effects on uptake of oxidized LDL","volume":"138","author":"Jay","year":"2018","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4419-6741-1_1","article-title":"An overview of sphingolipid metabolism: From synthesis to breakdown","volume":"688","author":"Gault","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1210\/en.2010-0250","article-title":"Saturated- and n-6 polyunsaturated-fat diets each induce ceramide accumulation in mouse skeletal muscle: Reversal and improvement of glucose tolerance by lipid metabolism inhibitors","volume":"151","author":"Frangioudakis","year":"2010","journal-title":"Endocrinology"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1096\/fj.04-2284fje","article-title":"Ceramide down-regulates System A amino acid transport and protein synthesis in rat skeletal muscle cells","volume":"19","author":"Hyde","year":"2005","journal-title":"FASEB J."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Finicle, B.T., Ramirez, M.U., Liu, G., Selwan, E.M., McCracken, A.N., Yu, J., Joo, Y., Nguyen, J., Ou, K., and Roy, S.G. (2018). Sphingolipids inhibit endosomal recycling of nutrient transporters by inactivating ARF6. J. Cell Sci., 131.","DOI":"10.1242\/jcs.213314"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"17402","DOI":"10.1073\/pnas.0802781105","article-title":"Ceramide starves cells to death by downregulating nutrient transporter proteins","volume":"105","author":"Guenther","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1074\/jbc.M112.402719","article-title":"Ablation of ceramide synthase 2 causes chronic oxidative stress due to disruption of the mitochondrial respiratory chain","volume":"288","author":"Zigdon","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1042\/BJ20070936","article-title":"Targeting of PKCzeta and PKB to caveolin-enriched microdomains represents a crucial step underpinning the disruption in PKB-directed signalling by ceramide","volume":"410","author":"Hajduch","year":"2008","journal-title":"Biochem. J."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.plipres.2015.09.002","article-title":"Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate","volume":"61","author":"Presa","year":"2016","journal-title":"Prog. Lipid Res."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.bbalip.2013.02.001","article-title":"New insights on the role of ceramide 1-phosphate in inflammation","volume":"1831","author":"Gangoiti","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"4806541","DOI":"10.1155\/2017\/4806541","article-title":"The Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Inflammation and Cancer","volume":"2017","author":"Hait","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.plipres.2005.11.002","article-title":"Ceramides in insulin resistance and lipotoxicity","volume":"45","author":"Summers","year":"2006","journal-title":"Prog. Lipid Res."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12944-020-01278-8","article-title":"Alveolar lipids in pulmonary disease. A review","volume":"19","author":"Agudelo","year":"2020","journal-title":"Lipids Health Dis."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1183\/09031936.00216914","article-title":"Disruption of pulmonary lipid homeostasis drives cigarette smoke-induced lung inflammation in mice","volume":"46","author":"Morissette","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Agudelo, C.W., Kumley, B.K., Area-Gomez, E., Xu, Y., Dabo, A.J., Geraghty, P., Campos, M., Foronjy, R., and Garcia-Arcos, I. (2020). Decreased surfactant lipids correlate with lung function in chronic obstructive pulmonary disease (COPD). PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0228279"},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Lugg, S.T., Scott, A., Parekh, D., Naidu, B., and Thickett, D.R. (2021). Cigarette smoke exposure and alveolar macrophages: Mechanisms for lung disease. Thorax.","DOI":"10.1136\/thoraxjnl-2020-216296"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.mayocp.2017.03.020","article-title":"Chronic Obstructive Pulmonary Disease Phenotypes: Implications for Care","volume":"92","author":"Mirza","year":"2017","journal-title":"Mayo Clin. Proc."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pulmoe.2019.10.006","article-title":"Chronic obstructive pulmonary disease and phenotypes: A state-of-the-art","volume":"26","author":"Corlateanu","year":"2020","journal-title":"Pulmonology"},{"key":"ref_184","first-page":"101","article-title":"Understanding COPD: A vision on phenotypes, comorbidities and treatment approach","volume":"22","author":"Fragoso","year":"2016","journal-title":"Rev. Port. Pneumol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"608","DOI":"10.4103\/2230-8210.139212","article-title":"Chronic obstructive pulmonary disease and the metabolic syndrome: Consequences of a dual threat","volume":"18","author":"Naik","year":"2014","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1164\/ajrccm\/140.3_Pt_2.S3","article-title":"Chronic obstructive pulmonary disease: A definition and implications of structural determinants of airflow obstruction for epidemiology","volume":"140","author":"Snider","year":"1989","journal-title":"Am. Rev. Respir. Dis."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/thx.2008.097543","article-title":"Body mass index in male patients with COPD: Correlation with low attenuation areas on CT","volume":"64","author":"Ogawa","year":"2009","journal-title":"Thorax"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1164\/rccm.200405-651OC","article-title":"Early emphysema in patients with anorexia nervosa","volume":"170","author":"Coxson","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12931-019-1073-3","article-title":"It\u2019s more than low BMI: Prevalence of cachexia and associated mortality in COPD","volume":"20","author":"McDonald","year":"2019","journal-title":"Respir. Res."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"00902","DOI":"10.1183\/23120541.00902-2020","article-title":"Challenging the obesity paradox: Extreme obesity and COPD mortality in the SUMMIT trial","volume":"7","author":"Brigham","year":"2021","journal-title":"ERJ Open Res."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2147\/COPD.S75175","article-title":"Paradoxical association between body mass index and in-hospital mortality in elderly patients with chronic obstructive pulmonary disease in Japan","volume":"9","author":"Yamauchi","year":"2014","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00408-011-9296-1","article-title":"Diabetes, impaired glucose tolerance, and metabolic biomarkers in individuals with normal glucose tolerance are inversely associated with lung function: The Jackson Heart Study","volume":"189","author":"Hickson","year":"2011","journal-title":"Lung"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1183\/09031936.00112411","article-title":"Metabolic profiling detects biomarkers of protein degradation in COPD patients","volume":"40","author":"Ubhi","year":"2012","journal-title":"Eur. Respir. J."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1164\/rccm.2203022","article-title":"Association between glycemic state and lung function: The Framingham Heart Study","volume":"167","author":"Walter","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/aje\/kwi076","article-title":"Lung function and glucose metabolism: An analysis of data from the Third National Health and Nutrition Examination Survey","volume":"161","author":"McKeever","year":"2005","journal-title":"Am. J. Epidemiol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"752","DOI":"10.2337\/diacare.27.3.752","article-title":"Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: The Fremantle Diabetes Study","volume":"27","author":"Davis","year":"2004","journal-title":"Diabetes Care"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/j.1464-5491.2010.03112.x","article-title":"The relationship between low vital capacity and impaired glucose metabolism in men","volume":"27","author":"Nakajima","year":"2010","journal-title":"Diabet. Med."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1464-5491.2010.03073.x","article-title":"Systematic review of the association between lung function and Type 2 diabetes mellitus","volume":"27","author":"Klein","year":"2010","journal-title":"Diabet. Med."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1378\/chest.09-2622","article-title":"Pulmonary function in diabetes: A metaanalysis","volume":"138","author":"Gosker","year":"2010","journal-title":"Chest"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.mayocp.2012.04.016","article-title":"Low lung function and risk of type 2 diabetes in Japanese men: The Toranomon Hospital Health Management Center Study 9 (TOPICS 9)","volume":"87","author":"Heianza","year":"2012","journal-title":"Mayo Clin. Proc."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1475-2840-11-38","article-title":"Reduced lung function is independently associated with increased risk of type 2 diabetes in Korean men","volume":"11","author":"Kwon","year":"2012","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1464-5491.2002.00652.x","article-title":"Risk of developing diabetes is inversely related to lung function: A population-based cohort study","volume":"19","author":"Janzon","year":"2002","journal-title":"Diabet. Med."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.2337\/diacare.27.10.2478","article-title":"Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women","volume":"27","author":"Rana","year":"2004","journal-title":"Diabetes Care"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2337\/dc07-1464","article-title":"Cross-sectional and prospective study of lung function in adults with type 2 diabetes: The Atherosclerosis Risk in Communities (ARIC) study","volume":"31","author":"Yeh","year":"2008","journal-title":"Diabetes Care"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.2337\/dc10-0324","article-title":"Lung function and risk of type 2 diabetes and fatal and nonfatal major coronary heart disease events: Possible associations with inflammation","volume":"33","author":"Wannamethee","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1161\/01.CIR.0000037220.00065.0D","article-title":"Lung function and cardiovascular risk: Relationship with inflammation-sensitive plasma proteins","volume":"106","author":"Lind","year":"2002","journal-title":"Circulation"},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Fujii, W., Kapellos, T.S., Ba\u00dfler, K., H\u00e4ndler, K., Holsten, L., Knoll, R., Warnat-Herresthal, S., Oestreich, M., Hinkley, E.R., and Hasenauer, J. (2021). Alveolar macrophage transcriptomic profiling in COPD shows major lipid metabolism changes. ERJ Open Res., 7.","DOI":"10.1183\/23120541.00915-2020"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1164\/rccm.200910-1580OC","article-title":"ATP-binding cassette transporter G1 deficiency dysregulates host defense in the lung","volume":"182","author":"Draper","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.4049\/jimmunol.180.6.4273","article-title":"A critical role for ABCG1 in macrophage inflammation and lung homeostasis","volume":"180","author":"Wojcik","year":"2008","journal-title":"J. Immunol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.4049\/jimmunol.180.5.3560","article-title":"Loss of ABCG1 results in chronic pulmonary inflammation","volume":"180","author":"Gomes","year":"2008","journal-title":"J. Immunol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"L980","DOI":"10.1152\/ajplung.00234.2005","article-title":"Pulmonary abnormalities due to ABCA1 deficiency in mice","volume":"289","author":"Bates","year":"2005","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.rmed.2011.07.011","article-title":"Lipid and smoker\u2019s inclusions in sputum macrophages in patients with airway diseases","volume":"105","author":"Wilson","year":"2011","journal-title":"Respir. Med."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2303.2009.00677.x","article-title":"Cut-off values and significance of Oil Red O-positive cells in bronchoalveolar lavage fluid","volume":"21","author":"Aziza","year":"2010","journal-title":"Cytopathology"},{"key":"ref_214","unstructured":"Chakinala, R.C., Khatri, A., Gupta, K., Koike, K., and Epelbaum, O. (2019). Sphingolipids in COPD. Eur. Respir. Rev., 28."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000341185","article-title":"Ceramide expression and cell homeostasis in chronic obstructive pulmonary disease","volume":"85","author":"Scarpa","year":"2013","journal-title":"Respiration"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"L125","DOI":"10.1152\/ajplung.00031.2009","article-title":"Neutral sphingomyelinase 2 is activated by cigarette smoke to augment ceramide-induced apoptosis in lung cell death","volume":"297","author":"Levy","year":"2009","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nm1238","article-title":"Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice","volume":"11","author":"Petrache","year":"2005","journal-title":"Nat. Med."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-3-7091-1511-4_12","article-title":"The involvement of sphingolipids in chronic obstructive pulmonary diseases","volume":"216","author":"Petrache","year":"2013","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1164\/rccm.201410-1771OC","article-title":"Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes","volume":"191","author":"Bowler","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"31596","DOI":"10.1038\/srep31596","article-title":"Structural and functional characterization of endothelial microparticles released by cigarette smoke","volume":"6","author":"Serban","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"S249","DOI":"10.1513\/AnnalsATS.201809-592MG","article-title":"Bioactive Sphingolipids in the Pathogenesis of Chronic Obstructive Pulmonary Disease","volume":"15","author":"Koike","year":"2018","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"8514056","DOI":"10.1155\/2016\/8514056","article-title":"Circulating Endothelial Microparticles: A Key Hallmark of Atherosclerosis Progression","volume":"2016","author":"Paudel","year":"2016","journal-title":"Scientifica"},{"key":"ref_223","first-page":"169","article-title":"Microparticles as potential biomarkers of cardiovascular disease","volume":"104","author":"Izar","year":"2015","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/CIRCRESAHA.110.233403","article-title":"Leukocyte-derived microparticles in vascular homeostasis","volume":"110","year":"2012","journal-title":"Circ. Res."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12931-020-01423-y","article-title":"Extracellular vesicles: Novel communicators in lung diseases","volume":"21","author":"Mohan","year":"2020","journal-title":"Respir. Res."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3389\/fbioe.2020.00369","article-title":"Endothelial Cell Morphology Regulates Inflammatory Cells Through MicroRNA Transferred by Extracellular Vesicles","volume":"8","author":"Liang","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"40322","DOI":"10.1074\/jbc.M110.137604","article-title":"Sphingolipid-mediated inhibition of apoptotic cell clearance by alveolar macrophages","volume":"285","author":"Petrusca","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2147\/COPD.S249534","article-title":"Sarcopenia Is an Independent Risk Factor for NAFLD in COPD: A Nationwide Survey (KNHANES 2008\u20132011)","volume":"15","author":"Hong","year":"2020","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1111\/liv.14626","article-title":"Pulmonary function is associated with fibrosis severity in patients with biopsy-proven nonalcoholic fatty liver disease","volume":"40","author":"Lee","year":"2020","journal-title":"Liver Int."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3892\/mmr.2012.758","article-title":"Role of liver X receptors in cholesterol efflux and inflammatory signaling (review)","volume":"5","author":"Zhu","year":"2012","journal-title":"Mol. Med. Rep."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1465-9921-14-106","article-title":"The role of the liver X receptor in chronic obstructive pulmonary disease","volume":"14","author":"Higham","year":"2013","journal-title":"Respir. Res."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1440-1843.2012.02136.x","article-title":"Increased 25-hydroxycholesterol concentrations in the lungs of patients with chronic obstructive pulmonary disease","volume":"17","author":"Sugiura","year":"2012","journal-title":"Respirology"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1378\/chest.11-2091","article-title":"Increase of 27-hydroxycholesterol in the airways of patients with COPD: Possible role of 27-hydroxycholesterol in tissue fibrosis","volume":"142","author":"Kikuchi","year":"2012","journal-title":"Chest"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-065X.2012.01153.x","article-title":"Liver X receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis and immunity","volume":"249","author":"Kidani","year":"2012","journal-title":"Immunol. Rev."},{"key":"ref_235","first-page":"689","article-title":"Orphan nuclear receptors: From gene to function","volume":"20","year":"1999","journal-title":"Endocr. Rev."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1146\/annurev.cellbio.20.012103.134432","article-title":"Nuclear receptors in macrophage biology: At the crossroads of lipid metabolism and inflammation","volume":"20","author":"Castrillo","year":"2004","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1475-2891-13-17","article-title":"Peroxisome proliferator-activated receptors and their ligands: Nutritional and clinical implications--a review","volume":"13","year":"2014","journal-title":"Nutr. J."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.1074\/jbc.M113.536805","article-title":"Down-regulated peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) in lung epithelial cells promotes a PPAR\u03b3 agonist-reversible proinflammatory phenotype in chronic obstructive pulmonary disease (COPD)","volume":"289","author":"Lakshmi","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1172\/JCI70587","article-title":"Agonistic induction of PPAR\u03b3 reverses cigarette smoke-induced emphysema","volume":"124","author":"Shan","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"L293","DOI":"10.1152\/ajplung.00287.2014","article-title":"Airway epithelial cell PPAR\u03b3 modulates cigarette smoke-induced chemokine expression and emphysema susceptibility in mice","volume":"309","author":"Solleti","year":"2015","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1183\/09031936.00068207","article-title":"Peroxisome proliferator-activated receptors: A therapeutic target in COPD?","volume":"31","author":"Remels","year":"2008","journal-title":"Eur. Respir. J."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1183\/09031936.00004314","article-title":"Impacts of peroxisome proliferator-activated receptor-\u03b3 activation on cigarette smoke-induced exacerbated response to bacteria","volume":"45","author":"Morissette","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/83348","article-title":"PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway","volume":"7","author":"Chinetti","year":"2001","journal-title":"Nat. Med."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.atherosclerosis.2011.07.113","article-title":"Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1\/ABCG1 expressions via PPAR\u03b3\/LXR\u03b1 pathway: Findings from in vitro and ex vivo studies","volume":"219","author":"Ozasa","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.3390\/ijms11093375","article-title":"Cigarette smoke affects ABCAl expression via liver X receptor nuclear translocation in human keratinocytes","volume":"11","author":"Sticozzi","year":"2010","journal-title":"Int. J. Mol. Sci."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.4049\/jimmunol.180.5.3305","article-title":"Effects of liver X receptor agonist treatment on pulmonary inflammation and host defense","volume":"180","author":"Smoak","year":"2008","journal-title":"J. Immunol."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1111\/j.1742-4658.2005.04599.x","article-title":"Liver X receptor agonists inhibit tissue factor expression in macrophages","volume":"272","author":"Terasaka","year":"2005","journal-title":"FEBS J."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nm820","article-title":"Reciprocal regulation of inflammation and lipid metabolism by liver X receptors","volume":"9","author":"Joseph","year":"2003","journal-title":"Nat. Med."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"31882","DOI":"10.1074\/jbc.M703278200","article-title":"Novel role for the liver X nuclear receptor in the suppression of lung inflammatory responses","volume":"282","author":"Birrell","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1164\/rccm.200611-1717OC","article-title":"Overweight, obesity, and incident asthma: A meta-analysis of prospective epidemiologic studies","volume":"175","author":"Beuther","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1164\/ajrccm.171.12.950","article-title":"Reduction in plasma free fatty acid in patients with chronic obstructive pulmonary disease","volume":"171","author":"Wada","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1165\/rcmb.2016-0282OC","article-title":"Genetic Control of Fatty Acid \u03b2-Oxidation in Chronic Obstructive Pulmonary Disease","volume":"56","author":"Jiang","year":"2017","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"ref_253","doi-asserted-by":"crossref","unstructured":"Cornell, K., Alam, M., Lyden, E., Wood, L., LeVan, T.D., Nordgren, T.M., Bailey, K., and Hanson, C. (2019). Saturated Fat Intake Is Associated with Lung Function in Individuals with Airflow Obstruction: Results from NHANES 2007\u20132012. Nutrients, 11.","DOI":"10.3390\/nu11020317"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"630910","DOI":"10.3389\/fphys.2020.630910","article-title":"Elevated CO","volume":"11","author":"Ceco","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3389\/fphar.2019.00941","article-title":"Cigarette Smoke Reduces Fatty Acid Catabolism, Leading to Apoptosis in Lung Endothelial Cells: Implication for Pathogenesis of COPD","volume":"10","author":"Gong","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_256","first-page":"224","article-title":"Dynamic differences in dietary polyunsaturated fatty acid metabolism in sputum of COPD patients and controls","volume":"1864","author":"Heijink","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell. Biol. Lipids"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12931-018-0919-4","article-title":"Dietary \u03c9-6 polyunsaturated fatty acid arachidonic acid increases inflammation, but inhibits ECM protein expression in COPD","volume":"19","author":"Rutting","year":"2018","journal-title":"Respir. Res."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: Mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_259","doi-asserted-by":"crossref","unstructured":"Kotlyarov, S., and Kotlyarova, A. (2021). Molecular Mechanisms of Lipid Metabolism Disorders in Infectious Exacerbations of Chronic Obstructive Pulmonary Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147634"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"413735","DOI":"10.1155\/2013\/413735","article-title":"Inflammation and immune response in COPD: Where do we stand?","volume":"2013","author":"Rovina","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"110785","DOI":"10.1016\/j.biopha.2020.110785","article-title":"The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling","volume":"131","author":"Shabalala","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3350\/cmh.2018.0011","article-title":"The Association of leptin with severity of non-alcoholic fatty liver disease: A population-based study","volume":"24","author":"Rotundo","year":"2018","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1463-1326.2005.00510.x","article-title":"Adiponectin\u2014A key adipokine in the metabolic syndrome","volume":"8","author":"Whitehead","year":"2006","journal-title":"Diabetes Obes. Metab."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1164\/rccm.202009-3533SO","article-title":"Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease","volume":"203","author":"Halpin","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1753944717711379","article-title":"Metabolic syndrome: Pathophysiology, management, and modulation by natural compounds","volume":"11","author":"Rochlani","year":"2017","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.4103\/jfmpc.jfmpc_482_19","article-title":"Systemic inflammation in patients of chronic obstructive pulmonary disease with metabolic syndrome","volume":"8","author":"Naseem","year":"2019","journal-title":"J. Family Med. Prim. Care"},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"9361","DOI":"10.1128\/MCB.23.24.9361-9374.2003","article-title":"Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation","volume":"23","author":"Hu","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"ref_268","first-page":"4553","article-title":"Role of the HIF-1 signaling pathway in chronic obstructive pulmonary disease","volume":"16","author":"Fu","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/resp.13722","article-title":"Hypoxia-inducible factor and bacterial infections in chronic obstructive pulmonary disease","volume":"25","author":"Shukla","year":"2020","journal-title":"Respirology"},{"key":"ref_270","doi-asserted-by":"crossref","unstructured":"Foglia, B., Novo, E., Protopapa, F., Maggiora, M., Bocca, C., Cannito, S., and Parola, M. (2021). Hypoxia, Hypoxia-Inducible Factors and Liver Fibrosis. Cells, 10.","DOI":"10.3390\/cells10071764"},{"key":"ref_271","doi-asserted-by":"crossref","unstructured":"Zhang, X., Huang, C., Li, X., Shangguan, Z., Wei, W., Liu, S., Yang, S., and Liu, Y. (2020). HFD and HFD-provoked hepatic hypoxia act as reciprocal causation for NAFLD via HIF-independent signaling. BMC Gastroenterol., 20.","DOI":"10.1186\/s12876-020-01515-5"},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/hep.29754","article-title":"Hypoxia-inducible factor 2\u03b1 drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine-rich glycoprotein","volume":"67","author":"Morello","year":"2018","journal-title":"Hepatology"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"E710","DOI":"10.1152\/ajpendo.00052.2019","article-title":"Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2\u03b1\/PPAR\u03b1 pathway","volume":"317","author":"Chen","year":"2019","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"14735","DOI":"10.1002\/jcb.28734","article-title":"Hypoxia inducible factor-1 promotes liver fibrosis in nonalcoholic fatty liver disease by activating PTEN\/p65 signaling pathway","volume":"120","author":"Han","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"ref_275","doi-asserted-by":"crossref","unstructured":"Mesarwi, O.A., Shin, M.K., Bevans-Fonti, S., Schlesinger, C., Shaw, J., and Polotsky, V.Y. (2016). Hepatocyte Hypoxia Inducible Factor-1 Mediates the Development of Liver Fibrosis in a Mouse Model of Nonalcoholic Fatty Liver Disease. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0168572"},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biochi.2014.10.013","article-title":"Hypoxia-inducible factor-1alpha in hepatic fibrosis: A promising therapeutic target","volume":"108","author":"Zhan","year":"2015","journal-title":"Biochimie"},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1096\/fj.10-159806","article-title":"Hypoxia-inducible protein 2 is a novel lipid droplet protein and a specific target gene of hypoxia-inducible factor-1","volume":"24","author":"Gimm","year":"2010","journal-title":"FASEB J."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"2548154","DOI":"10.1155\/2018\/2548154","article-title":"Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression","volume":"2018","author":"Tirosh","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1164\/rccm.202001-0078OC","article-title":"Endothelial HIF-2\u03b1 as a Key Endogenous Mediator Preventing Emphysema","volume":"202","author":"Pasupneti","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_280","doi-asserted-by":"crossref","unstructured":"Yoo, S., Takikawa, S., Geraghty, P., Argmann, C., Campbell, J., Lin, L., Huang, T., Tu, Z., Foronjy, R.F., and Feronjy, R. (2015). Integrative analysis of DNA methylation and gene expression data identifies EPAS1 as a key regulator of COPD. PLoS Genet., 11.","DOI":"10.1371\/journal.pgen.1004898"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/11\/2978\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:24:31Z","timestamp":1760167471000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/10\/11\/2978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":280,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["cells10112978"],"URL":"https:\/\/doi.org\/10.3390\/cells10112978","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,1]]}}}